Clinical trial
Quantiferon - CMV and the Prediction of CMV Infection In High Risk Solid Organ Transplant Recipients
NCT00817908 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Quantiferon - CMV and the Prediction of CMV Infection In High Risk Solid Organ Transplant Recipients
- Lead sponsor
- University of Alberta
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2008
- Completion date
- April 30, 2012
- Enrollment
- 131 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cytomegalovirus infection